213 related articles for article (PubMed ID: 28647472)
1. [Acute fatty liver of pregnancy and mitochondrial fatty acid oxidation. Consequences for the offspring].
Anon B; Barbet C; Gendrot C; Labarthe F; Bacq Y
Arch Pediatr; 2017 Aug; 24(8):777-782. PubMed ID: 28647472
[TBL] [Abstract][Full Text] [Related]
2. Exercise testing in metabolic myopathies.
Tarnopolsky M
Phys Med Rehabil Clin N Am; 2012 Feb; 23(1):173-86, xii. PubMed ID: 22239882
[TBL] [Abstract][Full Text] [Related]
3. Activity and mRNA levels of enzymes involved in hepatic fatty acid synthesis and oxidation in mice fed conjugated linoleic acid.
Takahashi Y; Kushiro M; Shinohara K; Ide T
Biochim Biophys Acta; 2003 Apr; 1631(3):265-73. PubMed ID: 12668178
[TBL] [Abstract][Full Text] [Related]
4. Management of fatty acid oxidation disorders: a survey of current treatment strategies.
Solis JO; Singh RH
J Am Diet Assoc; 2002 Dec; 102(12):1800-3. PubMed ID: 12487544
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
Goetzman ES; Tian L; Wood PA
Mol Genet Metab; 2005 Jan; 84(1):39-47. PubMed ID: 15639194
[TBL] [Abstract][Full Text] [Related]
6. Medium-chain fatty acids undergo elongation before beta-oxidation in fibroblasts.
Jones PM; Butt Y; Messmer B; Boriak R; Bennett MJ
Biochem Biophys Res Commun; 2006 Jul; 346(1):193-7. PubMed ID: 16750167
[TBL] [Abstract][Full Text] [Related]
7. New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties.
Koltun DO; Marquart TA; Shenk KD; Elzein E; Li Y; Nguyen M; Kerwar S; Zeng D; Chu N; Soohoo D; Hao J; Maydanik VY; Lustig DA; Ng KJ; Fraser H; Zablocki JA
Bioorg Med Chem Lett; 2004 Jan; 14(2):549-52. PubMed ID: 14698201
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for channelling mechanism of a fatty acid beta-oxidation multienzyme complex.
Ishikawa M; Tsuchiya D; Oyama T; Tsunaka Y; Morikawa K
EMBO J; 2004 Jul; 23(14):2745-54. PubMed ID: 15229654
[TBL] [Abstract][Full Text] [Related]
9. Incidence and short-term outcome of children with symptomatic presentation of organic acid and fatty acid oxidation disorders in Germany.
Klose DA; Kölker S; Heinrich B; Prietsch V; Mayatepek E; von Kries R; Hoffmann GF
Pediatrics; 2002 Dec; 110(6):1204-11. PubMed ID: 12456920
[TBL] [Abstract][Full Text] [Related]
10. The structure of the multienzyme complex of fatty acid oxidation from Escherichia coli.
Pawar S; Schulz H
J Biol Chem; 1981 Apr; 256(8):3894-9. PubMed ID: 7012144
[No Abstract] [Full Text] [Related]
11. Exploring options for expanded newborn screening.
Baily MA; Becker W; Hayes M; Clayton EW; Grosse S
J Law Med Ethics; 2005; 33(4 Suppl):46-8. PubMed ID: 16689158
[No Abstract] [Full Text] [Related]
12. Histidine-450 is the catalytic residue of L-3-hydroxyacyl coenzyme A dehydrogenase associated with the large alpha-subunit of the multienzyme complex of fatty acid oxidation from Escherichia coli.
He XY; Yang SY
Biochemistry; 1996 Jul; 35(29):9625-30. PubMed ID: 8755745
[TBL] [Abstract][Full Text] [Related]
13. Acute fatty liver of pregnancy.
Bacq Y
Semin Perinatol; 1998 Apr; 22(2):134-40. PubMed ID: 9638907
[TBL] [Abstract][Full Text] [Related]
14. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha.
Gerhart-Hines Z; Rodgers JT; Bare O; Lerin C; Kim SH; Mostoslavsky R; Alt FW; Wu Z; Puigserver P
EMBO J; 2007 Apr; 26(7):1913-23. PubMed ID: 17347648
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the fatty acid oxidation complex in acetyl-CoA-dependent chain elongation of fatty acids in Escherichia coli.
Nishimaki-Mogami T; Yamanaka H; Mizugaki M
J Biochem; 1987 Aug; 102(2):427-32. PubMed ID: 3312186
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of long-chain fatty acid oxidation disorders using alternative precursors and acylcarnitine profiling in fibroblasts.
Roe DS; Yang BZ; Vianey-Saban C; Struys E; Sweetman L; Roe CR
Mol Genet Metab; 2006 Jan; 87(1):40-7. PubMed ID: 16297647
[TBL] [Abstract][Full Text] [Related]
17. [Mass Screening for Inborn Errors of Metabolism].
Ito T
Rinsho Byori; 2015 Apr; 63(4):441-9. PubMed ID: 26536777
[TBL] [Abstract][Full Text] [Related]
18. Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats.
Halvorsen B; Rustan AC; Madsen L; Reseland J; Berge RK; Sletnes P; Christiansen EN
Ann Nutr Metab; 2001; 45(1):30-7. PubMed ID: 11244185
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
[TBL] [Abstract][Full Text] [Related]
20. Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes.
Sim WC; Kim DG; Lee W; Sim H; Choi YJ; Lee BH
Cell Biol Toxicol; 2019 Oct; 35(5):457-470. PubMed ID: 30721374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
